𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A point mutation associated with a severe phenotype of neurofibromatosis 2

✍ Scribed by Dr M. MaCcollin; Kevin Davis; N. Braverman; D. Viskochil; M. Ruttledge; R. Ojemann; J. Gusella; D. M. Parry


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
563 KB
Volume
40
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Neurofibromatosis 2 (NF2) is an autosomal dominant disease characterized by bilateral vestibular schwannomas and other nonmalignant tumors of the brain, spinal cord, and peripheral nerves. Although the average age of onset of NF2 is 20 years, some individuals may become symptomatic in childhood. We studied 5 unrelated NF2 patients who became symptomatic before age 13. All 5 had multiple tumors in addition to vestibular schwannoma, and none had a positive family history. Sequence analysis of the NF2 gene revealed identical nonsense mutation of exon 6 in 3 patients. Because this mutation destroys a restriction site, genomic DNA from the 2 other children was directly tested for this change and identical alterations were detected. Although the work of our laboratory and others has not, in general, detected identical mutations in unrelated patients, this mutation seems to occur particularly frequently in the pediatric population and thus may be associated with an especially severe phenotype. Restriction analysis in children with NF2 may be a cost effective way of identifying their mutation. Further work is needed to characterize the effects of this change on the NF2 protein product and its relationship to this severe phenotype.


πŸ“œ SIMILAR VOLUMES


A common mutation for mucopolysaccharido
✍ Hamish S. Scott; Tom Litjens; John J. Hopwood; C. Phillip Morris πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 612 KB

Communicated by William S. Sly Mucopolysaccharidosis type I (MI'S-I) is an autosomal recessive genetic disease caused by a deficiency of the glycosidase a-L-iduronidase which is required for the lysosomal degradation of the glycosaminoglycans heparan sulfate and dermatan sulfate. Patients with MI'S-

Novel SOD1 N86K mutation is associated w
✍ Marcus Beck; Michael Sendtner; Klaus V. Toyka πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 259 KB

## Abstract Familial amyotrophic lateral sclerosis (ALS) is frequently associated with mutations in the __SOD1__ gene. We identified a rapidly progressive disease in a patient with an inherited ALS. The identified heterozygous T>A exchange in position 1067 in the __SOD1__ gene results in an amino a

Severe phenotype of neurofibromatosis ty
✍ Carl E.G. Bruder; Koichi Ichimura; Elisabeth Blennow; Tatsuro Ikeuchi; Takekane πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 186 KB

Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder predisposing to multiple neoplastic lesions with the hallmark of schwannoma arising at the eighth cranial nerve. NF2 shows a distinct clinical variability, with a mild and a severe form of the disease. The NF2 gene is mutated in consti